Fibrillin-3 is a protein that is part of the fibrillin family, which also includes fibrillin-1 and fibrillin-2. These proteins are vital components of the extracellular matrix, specifically the microfibrils, which provide both structural support and elasticity to connective tissues. Fibrillins play essential roles in the formation and function of elastic fibers, and they also participate in cell signaling by modulating the bioavailability of transforming growth factor-beta (TGF-β), a powerful regulator of cellular processes. Fibrillin-3, in particular, has been identified in various tissues, and mutations or dysregulation of this protein have been linked to certain genetic and connective tissue disorders. The precise role of fibrillin-3 in relation to its family members remains a topic of research, but it's clear that it contributes significantly to the structural and functional integrity of tissues where it's expressed.
Fibrillin-3 inhibitors are compounds designed to modulate the activity or expression of fibrillin-3. By targeting fibrillin-3, these inhibitors can influence the structural composition and signaling processes of the extracellular matrix where fibrillin-3 is found. Given the role of fibrillin-3 in the formation of microfibrils and its impact on TGF-β signaling, inhibiting its function can lead to changes in tissue elasticity, integrity, and cellular signaling pathways. In a research context, these inhibitors can be invaluable tools. They allow for the exploration of fibrillin-3's function in various physiological and pathological processes, helping to delineate its role in health and disease. Additionally, understanding how these inhibitors interact with fibrillin-3 can provide insights into the protein's structure, function, and its relationship with other components of the extracellular matrix. As with all inhibitors, understanding their specificity, potency, and mode of action is crucial for their effective utilization in scientific studies.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Batimastat | 130370-60-4 | sc-203833 sc-203833A | 1 mg 10 mg | $179.00 $377.00 | 24 | |
MMP inhibitor which might indirectly influence fibrillin-3 by affecting ECM remodeling. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
Another MMP inhibitor, could play a role in maintaining the ECM and indirectly influence fibrillin-3. | ||||||
Doxycycline Hyclate | 24390-14-5 | sc-204734B sc-204734 sc-204734A sc-204734C | 100 mg 1 g 5 g 25 g | $27.00 $50.00 $105.00 $194.00 | 25 | |
Known to inhibit MMPs and could potentially have an indirect effect on fibrillin-3. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
Might influence oxidative stress and ECM remodeling, potentially affecting fibrillin-3 indirectly. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Used for hypertension, but has shown effects on TGF-β signaling and might influence ECM proteins, including fibrillin-3. | ||||||
Halofuginone | 55837-20-2 | sc-507290 | 100 mg | $1775.00 | ||
Inhibits collagen type I synthesis and might indirectly influence fibrillin-3. | ||||||
2-Methoxyestradiol | 362-07-2 | sc-201371 sc-201371A | 10 mg 50 mg | $71.00 $288.00 | 6 | |
Affects ECM remodeling and angiogenesis; could indirectly influence fibrillin-3. | ||||||
Pirfenidone | 53179-13-8 | sc-203663 sc-203663A | 10 mg 50 mg | $102.00 $416.00 | 6 | |
Known to affect TGF-β signaling and ECM formation, it might indirectly influence fibrillin-3. | ||||||